Kabiven

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, the active ingredient in Kabiven, is a parenteral nutrition presented as a solution for injection for intravenous use. It provides essential amino acids to patients who cannot receive enteral feeding, supporting protein synthesis and metabolic needs.

GNH USA supplies Kabiven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kabiven is an amino acid solution used in parenteral nutrition to meet protein and metabolic requirements. - Parenteral nutrition for patients unable to receive enteral feeding: provides essential amino acids to sustain nutrition. - Postoperative support: assists recovery by supplying building blocks for tissue repair. - Critical illness or trauma care: helps maintain nitrogen balance and supports metabolic demands.

Kabiven may be associated with infusion‑related and metabolic adverse reactions.

Common Side Effects: - Phlebitis at infusion site: inflammation of the vein. - Mild hypernatremia: slight increase in serum sodium. - Transient elevation of liver enzymes: mild rise in ALT/AST. - Electrolyte imbalance: minor shifts in potassium or calcium.

Serious or Rare Side Effects: - Severe hypersensitivity reaction: anaphylaxis, rash, bronchospasm. - Metabolic acidosis: significant drop in blood pH. - Hyperammonemia: elevated ammonia levels. - Thrombophlebitis: clot formation with vein inflammation.

When using Kabiven, clinicians should observe several safety measures. - Assess renal function: adjust infusion if creatinine clearance is reduced. - Monitor liver enzymes: watch for hepatic stress during prolonged use. - Check electrolyte levels: especially potassium, calcium, and sodium. - Observe for signs of infection at catheter site: prevent sepsis. - Use aseptic technique: ensure sterile preparation and administration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven can interact with other agents that affect electrolyte or metabolic balance.

Major Interactions (Avoid): - Concurrent high‑dose potassium supplements: may cause hyperkalemia. - Other parenteral nutrition solutions with overlapping amino acid profiles: risk of excess amino acid load.

Moderate Interactions (Monitor Closely): - Loop diuretics: can alter electrolyte balance, requiring monitoring. - Anticoagulants (heparin): infusion may affect clotting parameters. - Corticosteroids: may increase protein catabolism, affecting nutritional goals.